Seized Drug Analysis: Core Concepts and Exam Traps
What this domain covers
Seized drug analysis is the systematic identification of controlled substances in physical evidence. A candidate must understand the analytical screening-to-confirmation workflow, the logic of presumptive versus confirmatory testing, and the statistical and legal meaning of a result.
Concepts to master
- Presumptive (screening) tests - color tests, immunoassays, and microcrystalline tests. They are fast and sensitive but not specific; a positive result means "possibly present," never "identified."
- Confirmatory tests - typically a chromatographic separation coupled to a spectroscopic detector (GC-MS, LC-MS, FTIR). Identification rests on matching a retention time and a full spectrum to a reference standard run under the same conditions.
- Color test chemistry - know the reagent families (Marquis, Mecke, Mandelin, cobalt thiocyanate, Duquenois-Levine) and the trap that many drugs share a color response and that adulterants can mask or mimic results.
- Sampling and heterogeneity - seized material is rarely uniform; sampling plans and unit-by-unit analysis affect what a result can support.
- Quantitation and purity - distinguish identification from potency; quantitative methods require calibration and validated linearity.
Traps the exam favors
Questions often present a single positive color test and ask whether the drug is "identified." The correct answer is no - confirmation is required. Another trap conflates retention time match alone with identification; a full mass spectrum match is needed. Watch for questions implying that a negative screening test proves absence (false negatives occur at low concentration or with cross-reactivity gaps).
Rule of thumb
One test, one clue; two orthogonal tests, one identification. A defensible identification pairs a separation-based method with a spectral match to a concurrently run standard.
Worked example
A white powder gives a purple Marquis response. A candidate concluding "heroin" is overreaching: Marquis responds to many alkaloids. The defensible statement is "preliminary indication consistent with an opiate; confirmation pending."